Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2010
10/26/2010US7820182 Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
10/26/2010US7820181 Generating expression vectors comprising myxoviral gene sequences for use as tool in developing vaccines to prevent infection and respiratory sysytem disorders; genetic vaccines and viral diseases
10/26/2010US7820179 conjugated polymer biodrug for use in treating bone disorders likes osteoporosis or osteopenia, bone fracture
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820165 anti-epidermal growth factor receptor (EGFR) fusion protein; for development of diagnostics and therapeutics
10/26/2010US7820162 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/26/2010US7820157 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/26/2010CA2477922C Stabilizing agent for enzymes
10/26/2010CA2421438C Method for purifying recombinant proteins expressed as insoluble aggregates
10/26/2010CA2398707C C1 inhibitor produced in the milk of transgenic mammals
10/26/2010CA2351887C Psca: prostate stem cell antigen and uses thereof
10/26/2010CA2327349C Il-2 selective agonists and antagonists
10/26/2010CA2319211C Recombinant proteins derived from hgf and msp
10/26/2010CA2284733C Motilin homologs
10/26/2010CA2249409C Iga1 protease fragment as carrier peptide
10/26/2010CA2197717C Mycobacteria functional screening and/or expression vectors
10/26/2010CA2195752C Oligomeric carrier molecules with defined incorporated marker groups andhaptens
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/22/2010CA2721437A1 Method for manufacturing an aqueous glucose solution
10/21/2010WO2010121268A2 Regulation of aging by modulation of mitochondrial function
10/21/2010WO2010121259A2 Protein matrix for light-initiated electron transfer
10/21/2010WO2010120541A2 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/21/2010WO2010120524A2 Methods of modulating an immune response to a viral infection
10/21/2010WO2010120452A1 Dig-3 insecticidal cry toxins
10/21/2010WO2010120374A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010WO2010120121A2 Target-specific non-antibody protein and method for preparing the same
10/21/2010WO2010120069A2 Antigenic protein of black-lip pearl oyster egg extract, and method for assessing productive effort of black-lip pearl oyster using antibody specific to the protein
10/21/2010WO2010120054A2 Environmental stress-inducible 972 promoter isolated from rice and uses thereof
10/21/2010WO2010119997A1 Peptide having activity of transforming growth factor and production method therefor
10/21/2010WO2010119693A1 Method of screening for insulin secretion-potentiating agents
10/21/2010WO2010119420A1 3d matrices of human elastin-like polypeptides and method of preparation thereof
10/21/2010WO2010119362A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
10/21/2010WO2010119192A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
10/21/2010WO2010119191A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
10/21/2010WO2010119036A1 Novel post-translational fibrinogen variants
10/21/2010WO2010119021A1 Tenascin-w and brain cancers
10/21/2010WO2010118878A1 Muscle function enhancing peptide
10/21/2010WO2010118634A1 Insecticidal crystal protein gene cry30ga1, its encoded protein and uses
10/21/2010WO2010118633A1 Insecticidal crystal protein gene cry4cb1, its encoded protein and uses
10/21/2010WO2010118632A1 Bt protein cry4cb2, encoding gene of same and use thereof
10/21/2010WO2010118631A1 Insecticidal crystal protein gene cry56aa1, its encoded protein and uses
10/21/2010WO2010118630A1 Insecticidal crystal protein gene cry52ba1, its encoded protein and uses
10/21/2010WO2010118521A1 Peptide ligands for clusterin and uses thereof
10/21/2010WO2010099472A3 Spanx-b polypeptides and their use
10/21/2010WO2010099365A3 Pesticidal proteins and methods for their use
10/21/2010WO2010097788A3 Visfatin therapeutic agents for the treatment of acne and other conditions
10/21/2010WO2010091692A3 Constitutively active mutants of gpcr 88 and uses thereof
10/21/2010WO2010077005A3 Mycobacteria-derived polypeptide and polynucleotide, and method of screening anti-mycobacterial agent
10/21/2010WO2010060811A3 Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
10/21/2010WO2010059899A3 Vaccine for runting-stunting syndrome
10/21/2010WO2010042890A3 Polypeptides that bind trail-ri and trail-r2
10/21/2010WO2010015709A3 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof
10/21/2010WO2010015419A3 Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof
10/21/2010WO2009136297A3 Fusion polypeptides comprising glycosylated mucin for inhibiting toxin a from clostridium difficile
10/21/2010WO2008122434A8 Bis-met histones
10/21/2010US20100269229 Isolated Polynucleotide Molecules Corresponding to Mutant and Wild-Type Alleles of the Maize D9 Gene and Methods of Use
10/21/2010US20100269223 Dig-3 insecticidal cry toxins
10/21/2010US20100269221 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
10/21/2010US20100269217 Compositions and Methods for Altering the Morphology of Plants
10/21/2010US20100269213 Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
10/21/2010US20100269184 Apo-2DcR
10/21/2010US20100267936 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
10/21/2010US20100267931 Heterologous expression of neisserial proteins
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267928 Activatable diagnostic and therapeutic compound
10/21/2010US20100267927 Structure of the Insulin Receptor Ectodomain
10/21/2010US20100267846 Molecular delivery vehicle
10/21/2010US20100267651 T cell antigen receptor peptides
10/21/2010US20100267650 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs
10/21/2010US20100267649 Vascular adhesion molecules and modulation of their function
10/21/2010US20100267648 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/21/2010US20100267647 Modulating photoreactivity in a cell
10/21/2010US20100267645 Methods and compositions for treating ocular disease
10/21/2010US20100267644 Cystatin C as an Antagonist of TGF-BETA and Methods Related Thereto
10/21/2010US20100267638 Exosite-directed thrombin inhibitors
10/21/2010US20100267632 Treatment of neurodegenerative disorders
10/21/2010US20100267631 Apolipoprotein a-i mimics
10/21/2010US20100267628 Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes
10/21/2010US20100267625 Novel bacillus thuringiensis gene with coleopteran activity
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267617 Methods and compositions for mycoplasma pneumoniae exotoxins
10/21/2010US20100267613 Hypoallergenic cereal protein and uses thereof
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof
10/21/2010US20100267150 Hdm2 polypeptides
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100267138 Compositions and methods comprising a ligand of chemerinr
10/21/2010US20100267130 Chlamydomonas Intraflagellar Transport 88 (IFT-88)
10/21/2010US20100267129 Chimeric nucleic acids encoding polypeptides comprising domains of tnf family ligands
10/21/2010US20100267116 Filovirus vectors and noninfectious filovirus-based particles
10/21/2010US20100267113 Active truncated form of the rna polymerase of flavivirus
10/21/2010US20100267084 Protein glycosylation modification in methylotrophic yeast
10/21/2010US20100267056 Differential labelling method
10/21/2010US20100267045 Cudr as biomarker for cancer progression and therapeutic response
10/21/2010US20100267040 MN/CA IX and Cancer Prognosis
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100267024 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin
10/21/2010US20100267005 Crosslinking Within Coordination Complexes
1 ... 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 ... 2916